腱鞘炎の世界市場レポート 2025年

腱鞘炎市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.3％で、163億5,000万米ドルに成長します。予測期間中の成長は、スポーツやフィットネス活動への参加者の増加、高齢者人口の増加、早期腱損傷管理に対する意識の高まり、低侵襲処置の利用可能性の増加、ヘルスケアインフラの拡大、筋骨格系モニタリング用ウェアラブルデバイスの採用増加など、いくつかの要因に起因しています。この期間に予想される主な動向には、再生療法の採用、腱修復用生物製剤の開発、低侵襲手術手技の進歩、リハビリモニタリング用ウェアラブルデバイスの革新、疼痛管理製剤の改善、AI駆動診断ツールの統合などがあります。

スポーツ傷害の発生率の増加は、腱鞘炎市場の拡大を促進すると予想されます。スポーツ傷害とは、運動活動や運動中に負う身体的傷害を指し、軽度の捻挫やひずみから重度の骨折や脱臼に至るまで、さまざまなものがあります。スポーツ傷害の増加は、トレーニング強度の増加や若い年齢での競合に関連しており、完全に成熟する前の発育途上の筋肉や関節に過度のストレスがかかります。このような傷害は、腱に反復的なストレスや急激な過負荷を与え、微細な断裂や炎症、時間の経過に伴う変性を引き起こすことで、腱鞘炎につながる可能性があります。例えば、2023年11月、英国の保険仲介会社Howden Group Holdings Ltd.は、2022年10月から2023年1月の間に、イングランド・プレミアリーグにおける足首の怪我の重症度が170％増加し、2022年FIFAワールドカップ・カタール大会後には、ふくらはぎ/脛の怪我が200％、ハムストリングの怪我が130％増加したと報告しました。このように、スポーツ傷害の発生率の増加が腱鞘炎市場の成長に寄与しています。

腱鞘炎市場の主要企業は、治癒を促進し、腱の再生を改善し、回復時間を短縮するために、生体誘導性インプラントなどの先進製品の開発に注力しています。生体誘導性インプラントは、腱様組織の成長を促進することで身体の自然治癒プロセスを刺激し、腱修復における臨床結果の改善につながる革新的な医療機器です。例えば、2023年7月、英国の医療技術企業であるSmith+Nephew社は、インドでREGENETEN Bioinductive Implantを発売しました。このコラーゲンベースの器具は、特に腱板修復において、損傷部位の新組織成長を誘導することで生物学的治癒を促し、腱修復を一変させる。このインプラントの主な特徴は、低侵襲性の送達方法であり、整形外科医が既存の手術手技を変更することなく腱を生物学的に補強することを可能にし、腱鞘炎患者に迅速かつ安全で効果的な治療オプションを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の腱鞘炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腱鞘炎市場：成長率分析
• 世界の腱鞘炎市場の実績：規模と成長、2019年～2024年
• 世界の腱鞘炎市場の予測：規模と成長, 2024-2029、2034年
• 世界の腱鞘炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腱鞘炎市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• アキレス腱炎
• 回旋筋腱板腱炎
• 外側上顆炎（テニス肘）
• 膝蓋腱炎
• その他のタイプ
• 世界の腱鞘炎市場：治療タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 治療
• 薬
• 外科的治療
• 再生医療
• 世界の腱鞘炎市場：投与経路別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 経口
• 局所
• 注射剤
• 世界の腱鞘炎市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• クリニック
• 外来手術センター
• リハビリテーションセンター
• 世界の腱鞘炎市場、アキレス腱炎の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 挿入アキレス腱鞘炎
• 非挿入性アキレス腱腱鞘炎
• 世界の腱鞘炎市場、回旋筋腱板腱炎のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 棘上筋腱鞘炎
• 棘下筋腱鞘炎
• 肩甲下筋腱鞘炎
• テレス・マイナー腱鞘炎
• 世界の腱鞘炎市場、外側上顆炎（テニス肘）の分類（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
• 腱の使いすぎによる損傷
• 腱変性損傷
• 世界の腱鞘炎市場、膝蓋腱炎の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 膝蓋骨近位部腱鞘炎
• 遠位膝蓋骨腱鞘炎
• 世界の腱鞘炎市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• ド・ケルバン腱鞘炎
• 腓骨腱鞘炎
• フレクサー腱鞘炎
• エクステンサー腱鞘炎

第7章 地域別・国別分析

• 世界の腱鞘炎市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の腱鞘炎市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腱鞘炎市場：競合情勢
• 腱鞘炎市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi SA
• Bristol-Myers Squibb Company
• Novartis AG
• GSK plc
• Medtronic Plc
• 3M Company
• Stryker Corporation
• Teva Pharmaceutical Industries
• Zimmer Biomet
• Smith & Nephew plc
• Coloplast A/S
• Arthrex
• Bioventus
• Tynor Orthotics
• Almatica Pharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腱鞘炎市場2029年：新たな機会を提供する国
• 腱鞘炎市場2029年：新たな機会を提供するセグメント
• 腱鞘炎市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tendinopathy is a condition that affects the tendons, leading to pain, swelling, and reduced movement or strength. It is typically caused by repetitive stress or overuse, resulting in the deterioration of tendon tissue rather than acute inflammation.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of tendinopathy include Achilles tendinopathy, rotator cuff tendinopathy, lateral epicondylitis (tennis elbow), patellar tendinopathy, and others. Achilles tendinopathy specifically refers to an injury to the Achilles tendon, which connects the calf muscles to the heel bone. Treatment options for tendinopathy include therapy, medications, surgical interventions, and regenerative medicine approaches. The condition can be managed using various routes of administration, such as oral, topical, and injectable methods. These treatments are provided in various healthcare settings, including hospitals, clinics, and ambulatory surgical centers.

The tendinopathy market research report is one of a series of new reports from The Business Research Company that provides tendinopathy market statistics, including the tendinopathy industry global market size, regional shares, competitors with the tendinopathy market share, detailed tendinopathy market segments, market trends, and opportunities, and any further data you may need to thrive in the tendinopathy industry. This tendinopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tendinopathy market size has grown strongly in recent years. It will grow from$12.63 billion in 2024 to $13.32 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to several factors, including the rising incidence of sports-related injuries, a growing aging population, increased awareness of musculoskeletal disorders, the expanding availability of physical therapy services, and greater healthcare spending globally.

The tendinopathy market size is expected to see strong growth in the next few years. It will grow to$16.35 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth during the forecast period can be attributed to several factors, including increasing participation in sports and fitness activities, a rising geriatric population, growing awareness of early tendon injury management, the increasing availability of minimally invasive procedures, expanding healthcare infrastructure, and the rising adoption of wearable devices for musculoskeletal monitoring. Major trends expected during this period include the adoption of regenerative therapies, the development of biologics for tendon repair, advancements in minimally invasive surgical techniques, innovations in wearable devices for rehabilitation monitoring, improvements in pain management formulations, and the integration of AI-driven diagnostic tools.

The growing incidence of sports injuries is expected to drive the expansion of the tendinopathy market. Sports injuries refer to physical injuries sustained during athletic activities or exercise, ranging from minor sprains and strains to more severe fractures or dislocations. The rise in sports injuries is linked to increased training intensity and competition at younger ages, which places excessive stress on developing muscles and joints before they are fully matured. These injuries can lead to tendinopathy by subjecting tendons to repetitive stress or sudden overload, causing microscopic tears, inflammation, and degeneration over time. For example, in November 2023, Howden Group Holdings Ltd., a UK-based insurance intermediary company, reported that the severity of ankle injuries in the English Premier League increased by 170% between October 2022 and January 2023, while calf/shin injuries surged by 200% and hamstring injuries rose by 130%, following the FIFA World Cup Qatar 2022. As such, the rising incidence of sports injuries is contributing to the growth of the tendinopathy market.

Leading companies in the tendinopathy market are focusing on developing advanced products, such as bioinductive implants, to accelerate healing, improve tendon regeneration, and reduce recovery time. Bioinductive implants are innovative medical devices that stimulate the body's natural healing process by promoting the growth of tendon-like tissue, leading to improved clinical outcomes in tendon repair. For example, in July 2023, Smith+Nephew, a UK-based medical technology company, launched the REGENETEN Bioinductive Implant in India. This collagen-based device transforms tendon repair by encouraging biological healing through the induction of new tissue growth at the injury site, particularly for rotator cuff repairs. A key feature of the implant is its minimally invasive delivery method, which allows orthopedic surgeons to biologically reinforce the tendon without changing existing surgical techniques, offering a quicker, safer, and more effective treatment option for tendinopathy patients.

In April 2023, Vander-Bend Manufacturing, Inc., a U.S.-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. With this acquisition, Vander-Bend aims to expand its precision manufacturing capabilities, enhance its product offerings in the medical technology sector, and strengthen its position in the market by integrating Omni Components Corporation's expertise in producing complex, high-precision components. Omni Components Corporation is a U.S.-based medical device company specializing in tendon surgeries.

Major players in the tendinopathy market are Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GSK plc, Medtronic Plc, 3M Company, Stryker Corporation, Teva Pharmaceutical Industries, Zimmer Biomet, Smith & Nephew plc, Coloplast A/S, Arthrex, Bioventus, Tynor Orthotics, Almatica Pharma Inc.

North America was the largest region in the tendinopathy market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tendinopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tendinopathy market consists of revenues earned by entities by providing services such as physical therapy and rehabilitation programs, pain management, arthroscopic debridement, and occupational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The tendinopathy market also include sales of nonsteroidal anti-inflammatory drugs, creams and gels, and capsaicin creams. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tendinopathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tendinopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tendinopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tendinopathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Achilles Tendinopathy; Rotator Cuff Tendinopathy; Lateral Epicondylitis (Tennis Elbow); Patellar Tendinopathy; Other Types
• 2) By Treatment Type: Therapy; Medication; Surgical Treatment; Regenerative Medicine
• 3) By Route Of Administration: Oral; Topical; Injectable
• 4) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Rehabilitation Centers
• Subsegments:
• 1) By Achilles Tendinopathy: Insertional Achilles Tendinopathy; Non-insertional Achilles Tendinopathy
• 2) By Rotator Cuff Tendinopathy: Supraspinatus Tendinopathy; Infraspinatus Tendinopathy; Subscapularis Tendinopathy; Teres Minor Tendinopathy
• 3) By Lateral Epicondylitis (Tennis Elbow): Tendon Overuse Injuries; Tendon Degeneration Injuries
• 4) By Patellar Tendinopathy: Proximal Patellar Tendinopathy; Distal Patellar Tendinopathy
• 5) By Other Types: De Quervain's Tenosynovitis; Peroneal Tendinopathy; Flexor Tendinopathy; Extensor Tendinopathy
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tendinopathy Market Characteristics

3. Tendinopathy Market Trends And Strategies

4. Tendinopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tendinopathy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tendinopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tendinopathy Market Growth Rate Analysis
• 5.4. Global Tendinopathy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tendinopathy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tendinopathy Total Addressable Market (TAM)

6. Tendinopathy Market Segmentation

• 6.1. Global Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Achilles Tendinopathy
• Rotator Cuff Tendinopathy
• Lateral Epicondylitis (Tennis Elbow)
• Patellar Tendinopathy
• Other Types
• 6.2. Global Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapy
• Medication
• Surgical Treatment
• Regenerative Medicine
• 6.3. Global Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Injectable
• 6.4. Global Tendinopathy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Rehabilitation Centers
• 6.5. Global Tendinopathy Market, Sub-Segmentation Of Achilles Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insertional Achilles Tendinopathy
• Non-insertional Achilles Tendinopathy
• 6.6. Global Tendinopathy Market, Sub-Segmentation Of Rotator Cuff Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Supraspinatus Tendinopathy
• Infraspinatus Tendinopathy
• Subscapularis Tendinopathy
• Teres Minor Tendinopathy
• 6.7. Global Tendinopathy Market, Sub-Segmentation Of Lateral Epicondylitis (Tennis Elbow), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tendon Overuse Injuries
• Tendon Degeneration Injuries
• 6.8. Global Tendinopathy Market, Sub-Segmentation Of Patellar Tendinopathy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proximal Patellar Tendinopathy
• Distal Patellar Tendinopathy
• 6.9. Global Tendinopathy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• De Quervain's Tenosynovitis
• Peroneal Tendinopathy
• Flexor Tendinopathy
• Extensor Tendinopathy

7. Tendinopathy Market Regional And Country Analysis

• 7.1. Global Tendinopathy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tendinopathy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tendinopathy Market

• 8.1. Asia-Pacific Tendinopathy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tendinopathy Market

• 9.1. China Tendinopathy Market Overview
• 9.2. China Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tendinopathy Market

• 10.1. India Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tendinopathy Market

• 11.1. Japan Tendinopathy Market Overview
• 11.2. Japan Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tendinopathy Market

• 12.1. Australia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tendinopathy Market

• 13.1. Indonesia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tendinopathy Market

• 14.1. South Korea Tendinopathy Market Overview
• 14.2. South Korea Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tendinopathy Market

• 15.1. Western Europe Tendinopathy Market Overview
• 15.2. Western Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tendinopathy Market

• 16.1. UK Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tendinopathy Market

• 17.1. Germany Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tendinopathy Market

• 18.1. France Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tendinopathy Market

• 19.1. Italy Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tendinopathy Market

• 20.1. Spain Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tendinopathy Market

• 21.1. Eastern Europe Tendinopathy Market Overview
• 21.2. Eastern Europe Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tendinopathy Market

• 22.1. Russia Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tendinopathy Market

• 23.1. North America Tendinopathy Market Overview
• 23.2. North America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tendinopathy Market

• 24.1. USA Tendinopathy Market Overview
• 24.2. USA Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tendinopathy Market

• 25.1. Canada Tendinopathy Market Overview
• 25.2. Canada Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tendinopathy Market

• 26.1. South America Tendinopathy Market Overview
• 26.2. South America Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tendinopathy Market

• 27.1. Brazil Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tendinopathy Market

• 28.1. Middle East Tendinopathy Market Overview
• 28.2. Middle East Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tendinopathy Market

• 29.1. Africa Tendinopathy Market Overview
• 29.2. Africa Tendinopathy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tendinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tendinopathy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tendinopathy Market Competitive Landscape And Company Profiles

• 30.1. Tendinopathy Market Competitive Landscape
• 30.2. Tendinopathy Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Tendinopathy Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. Novartis AG
• 31.4. GSK plc
• 31.5. Medtronic Plc
• 31.6. 3M Company
• 31.7. Stryker Corporation
• 31.8. Teva Pharmaceutical Industries
• 31.9. Zimmer Biomet
• 31.10. Smith & Nephew plc
• 31.11. Coloplast A/S
• 31.12. Arthrex
• 31.13. Bioventus
• 31.14. Tynor Orthotics
• 31.15. Almatica Pharma Inc.

32. Global Tendinopathy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tendinopathy Market

34. Recent Developments In The Tendinopathy Market

35. Tendinopathy Market High Potential Countries, Segments and Strategies

• 35.1 Tendinopathy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tendinopathy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tendinopathy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34990_Tendinopathy_GMR_2025